Article category: Supervision CIRO releases annual report on major regulatory achievements Article label: Quick Read Julie DiMauro
Article category: Compliance Physician groups, patients challenge CMS Medicaid work rules Premium article Kevin Kinsella
Article category: Compliance SEC-FDA data-sharing pact raises scrutiny for life sciences firms Premium article Kevin Kinsella
Article category: Regulation FDA nominee backs vaccine safety, sidesteps abortion pill debate Article label: Quick Read Premium article Kevin Kinsella
Article category: FINRA FINRA has a new regulatory operations department Article label: Quick Read Thomas Hyrkiel
Article category: Regulation TrumpRx drug prices show mixed results against global benchmarks Premium article Kevin Kinsella
Article category: Security EU auditors say incident reporting gaps hamper bloc's cyber response Premium article Vasilka Lalevska
Article category: Security Preparing for post-quantum encryption: What organizations should do now Emma Burnett, CMS; Dr. Rachel Free, CMS
Article category: Fintech Few finfluencers have real financial qualifications, analysis finds Article label: Quick Read Carmen Cracknell
31:19 Podcast: 31 min listen Article category: Podcasts Alex Curran on CEO role, glass box AI and why we should ban "AI-powered" Jean Hurley
Article category: GRIP Extra GRIP Extra: FBI data stolen, Swiss parliament backs tough capital rules for UBS GRIP
Event: Sep 25, 2026 Article category: Event Vendor reliability, AI recordkeeping takeaways at GR compliance roundtable Premium article Alex Viall
Article category: Regulation FDA nominee backs vaccine safety, sidesteps abortion pill debate Article label: Quick Read Premium article Kevin Kinsella
Article category: FINRA FINRA has a new regulatory operations department Article label: Quick Read Thomas Hyrkiel
31:19 Podcast: 31 min listen Article category: Podcasts Alex Curran on CEO role, glass box AI and why we should ban "AI-powered" Jean Hurley
Article category: Audit Third‑party disclosure: a practical guide for pharmaceutical compliance and risk teams Principal third-party disclosure mechanisms and the common pitfalls for pharmaceutical compliance and risk teams. Kate Gee, Signature Litigation; Oliver Steeple, Signature Litigation Dec 23, 2025